Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I8V2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.582 |
DEG_SCF_FBW7_2 | 6 | 13 | PF00400 | 0.546 |
DOC_CKS1_1 | 7 | 12 | PF01111 | 0.552 |
DOC_PP4_MxPP_1 | 1 | 4 | PF00568 | 0.573 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.591 |
LIG_14-3-3_CanoR_1 | 26 | 33 | PF00244 | 0.509 |
LIG_APCC_ABBA_1 | 8 | 13 | PF00400 | 0.530 |
LIG_BRCT_BRCA1_1 | 34 | 38 | PF00533 | 0.417 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.502 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.469 |
LIG_FHA_2 | 7 | 13 | PF00498 | 0.477 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.550 |
LIG_LIR_Gen_1 | 16 | 27 | PF02991 | 0.412 |
LIG_LIR_Gen_1 | 48 | 58 | PF02991 | 0.454 |
LIG_LIR_Gen_1 | 78 | 89 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 16 | 22 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 78 | 84 | PF02991 | 0.524 |
LIG_Pex14_1 | 81 | 85 | PF04695 | 0.393 |
LIG_SH2_CRK | 19 | 23 | PF00017 | 0.494 |
LIG_SH2_GRB2like | 21 | 24 | PF00017 | 0.558 |
LIG_SH2_SRC | 21 | 24 | PF00017 | 0.484 |
LIG_SH2_STAP1 | 11 | 15 | PF00017 | 0.565 |
LIG_SH2_STAT3 | 62 | 65 | PF00017 | 0.552 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.558 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.477 |
LIG_SH3_3 | 1 | 7 | PF00018 | 0.551 |
LIG_TRAF2_1 | 10 | 13 | PF00917 | 0.577 |
MOD_CK2_1 | 6 | 12 | PF00069 | 0.490 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.536 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.423 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.514 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.456 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.529 |
MOD_N-GLC_1 | 13 | 18 | PF02516 | 0.552 |
MOD_N-GLC_1 | 33 | 38 | PF02516 | 0.409 |
MOD_N-GLC_1 | 75 | 80 | PF02516 | 0.512 |
MOD_N-GLC_1 | 85 | 90 | PF02516 | 0.539 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.428 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.458 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.539 |
MOD_PIKK_1 | 43 | 49 | PF00454 | 0.462 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.461 |
MOD_Plk_1 | 33 | 39 | PF00069 | 0.507 |
MOD_Plk_1 | 85 | 91 | PF00069 | 0.542 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.455 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.585 |
MOD_SUMO_rev_2 | 67 | 74 | PF00179 | 0.413 |
TRG_DiLeu_BaEn_1 | 48 | 53 | PF01217 | 0.491 |
TRG_ENDOCYTIC_2 | 19 | 22 | PF00928 | 0.501 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.477 |
TRG_Pf-PMV_PEXEL_1 | 42 | 47 | PF00026 | 0.433 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I217 | Leptomonas seymouri | 68% | 100% |
A0A0S4JGU8 | Bodo saltans | 58% | 98% |
A0A1X0P0S4 | Trypanosomatidae | 60% | 100% |
A0A3Q8IDN3 | Leishmania donovani | 100% | 100% |
A0A422P2N7 | Trypanosoma rangeli | 59% | 100% |
A4HLE3 | Leishmania braziliensis | 91% | 100% |
D0A4U8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 97% |
E9B3S1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4Q4A3 | Leishmania major | 96% | 100% |